1. Modulation of buprenorphine partial agonism by the opioid antagonist samidorphan: A mechanistic PK/PD model. (1st November 2015) Authors: Turncliff, Ryan; Li, W.I. Journal: Drug and alcohol dependence Issue: Volume 156(2015) Page Start: e226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Modulation of buprenorphine partial agonism by the opioid antagonist samidorphan: A mechanistic PK/PD model. (1st November 2015) Authors: Turncliff, Ryan; Li, W.I. Journal: Drug and alcohol dependence Issue: Volume 156(2015) Page Start: e226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Use of Remifentanil in a Novel Clinical Paradigm to Characterize Onset and Duration of Opioid Blockade by Samidorphan, a Potent μ-Receptor Antagonist. Issue 3 (June 2015) Authors: Shram, Megan J.; Silverman, Bernard; Ehrich, Elliot; Sellers, Edward M.; Turncliff, Ryan Journal: Journal of clinical psychopharmacology Issue: Volume 35:Issue 3(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Use of Remifentanil in a Novel Clinical Paradigm to Characterize Onset and Duration of Opioid Blockade by Samidorphan, a Potent μ-Receptor Antagonist. Issue 3 (June 2015) Authors: Shram, Megan J.; Silverman, Bernard; Ehrich, Elliot; Sellers, Edward M.; Turncliff, Ryan Journal: Journal of clinical psychopharmacology Issue: Volume 35:Issue 3(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗